New ASBrS and SBI Guidelines for Vacuum-Assisted Excision for Benign Breast Lesions

January 21, 2026

The American Society of Breast Surgeons (ASBrS) and the Society of Breast Imaging (SBI) have released updated clinical guidelines for the management of benign breast disease, marking a significant advancement in U.S. guidelines for patient care and procedural direction.

According to the newly published recommendations, vacuum-assisted excision (VAE) is considered an appropriate treatment option for biopsy-proven fibroadenomas. This assessment of VAE opens the door for broader adoption of minimally invasive technologies like the Mammotome Revolve™ EX Breast Biopsy System. Specifically designed for the excision of benign lesions, the Mammotome Revolve™ EX system offers precision, efficiency, and speed.

Clinicians seeking to implement these guidelines can rely on the Mammotome Revolve™ EX system to meet the procedural needs of eligible patients, offering a trusted solution backed by clinical innovation.

To read the full guidelines, visit the ASBrS announcement. For the published article in JAMA Surgery, click here.